Signal Transduction and Targeted Therapy· 2020Q1· Review
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
- 1,143citations
- Q1SCImago
- 2020year
Short summary
Epigenetic changes, altered transport, regulated cell death, and the tumor microenvironment drive sorafenib resistance in late-stage hepatocellular carcinoma (HCC).
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Hepatology
HepatologyMedicine